vTv Therapeutics Inc. is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates. The company's lead product candidate, cadisegliatin, is being evaluated as an adjunctive therapy to insulin for the treatment of type 1 diabetes.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.